Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

References for PMC Articles for PubMed (Select 20981248)

1.
2.

Immunological, paracrine and endocrine aspects of testicular immune privilege.

Meinhardt A, Hedger MP.

Mol Cell Endocrinol. 2011 Mar 15;335(1):60-8. doi: 10.1016/j.mce.2010.03.022. Epub 2010 Apr 2. Review.

PMID:
20363290
3.

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.

Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM.

Clin Cancer Res. 2009 Sep 1;15(17):5323-37. doi: 10.1158/1078-0432.CCR-09-0737.

4.

Cancer/testis (CT) antigens: potential targets for immunotherapy.

Caballero OL, Chen YT.

Cancer Sci. 2009 Nov;100(11):2014-21. doi: 10.1111/j.1349-7006.2009.01303.x. Epub 2009 Aug 1. Review.

PMID:
19719775
5.

Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.

Taylor DD, Gercel-Taylor C, Parker LP.

Gynecol Oncol. 2009 Oct;115(1):112-20. doi: 10.1016/j.ygyno.2009.06.031. Epub 2009 Jul 31.

6.

Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.

Martins I, Sylla K, Deshayes F, Lauriol J, Ghislin S, Dieu-Nosjean MC, Viguier M, Verola O, Charron D, Alcaide-Loridan C, Al-Daccak R.

Melanoma Res. 2009 Aug;19(4):226-37. doi: 10.1097/CMR.0b013e32832e0bc3.

PMID:
19574933
7.

Cancer-testis antigens: potential targets for cancer immunotherapy.

Ghafouri-Fard S, Modarressi MH.

Arch Iran Med. 2009 Jul;12(4):395-404. Review.

8.

Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells.

Held G, Neumann F, Sturm C, Kaestner L, Dauth N, de Bruijn DR, Renner C, Lipp P, Pfreundschuh M.

Int J Cancer. 2008 Oct 15;123(8):1841-7. doi: 10.1002/ijc.23728.

PMID:
18688854
9.

The mouse X chromosome is enriched for multicopy testis genes showing postmeiotic expression.

Mueller JL, Mahadevaiah SK, Park PJ, Warburton PE, Page DC, Turner JM.

Nat Genet. 2008 Jun;40(6):794-9. doi: 10.1038/ng.126. Epub 2008 May 4.

10.

Identification of a common HLA-A*0201-restricted epitope among SSX family members by mimicking altered peptide ligands strategy.

He Y, Mao L, Lin Z, Deng Y, Tang Y, Jiang M, Li W, Jia Z, Wang J, Ni B, Wu Y.

Mol Immunol. 2008 May;45(9):2455-64. doi: 10.1016/j.molimm.2008.01.014. Epub 2008 Mar 4.

PMID:
18295890
11.

Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status.

Sigalotti L, Covre A, Zabierowski S, Himes B, Colizzi F, Natali PG, Herlyn M, Maio M.

J Cell Physiol. 2008 May;215(2):287-91. doi: 10.1002/jcp.21380.

12.

SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients.

Guinn BA, Bullinger L, Thomas NS, Mills KI, Greiner J.

Br J Haematol. 2008 Jan;140(2):250-1. Epub 2007 Nov 19. No abstract available.

PMID:
18028484
13.
14.

SSX2IP: an emerging role in cancer.

Breslin A, Denniss FA, Guinn BA.

Biochem Biophys Res Commun. 2007 Nov 23;363(3):462-5. Epub 2007 Sep 24. Review.

PMID:
17904521
15.

The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells.

Denniss FA, Breslin A, Ingram W, Hardwick NR, Mufti GJ, Guinn BA.

Br J Haematol. 2007 Sep;138(5):668-9. No abstract available.

PMID:
17686061
16.

The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.

de Bruijn DR, van Dijk AH, Willemse MP, van Kessel AG.

Oncogene. 2008 Jan 24;27(5):653-62. Epub 2007 Jul 30.

PMID:
17667940
17.

Potential target antigens for immunotherapy in human pancreatic cancer.

Schmitz-Winnenthal FH, Galindo-Escobedo LV, Rimoldi D, Geng W, Romero P, Koch M, Weitz J, Krempien R, Niethammer AG, Beckhove P, Buchler MW, Z'graggen K.

Cancer Lett. 2007 Jul 18;252(2):290-8. Epub 2007 Feb 22.

PMID:
17320278
18.

Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.

Godefroy E, Wang Y, Souleimanian NE, Scotto L, Stevanovic S, Chen YT, Valmori D, Ayyoub M.

Cancer Immunol Immunother. 2007 Aug;56(8):1183-92. Epub 2006 Dec 22.

PMID:
17186289
19.

Cancer-testis antigen expression in bladder cancer.

Fradet Y, Picard V, Bergeron A, LaRue H.

Prog Urol. 2006 Sep;16(4):421-8. No abstract available.

PMID:
17069033
20.

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

Jäger E, Karbach J, Gnjatic S, Neumann A, Bender A, Valmori D, Ayyoub M, Ritter E, Ritter G, Jäger D, Panicali D, Hoffman E, Pan L, Oettgen H, Old LJ, Knuth A.

Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14453-8. Epub 2006 Sep 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk